Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1

ClinicalTrials.gov ID: NCT05680818

Public ClinicalTrials.gov record NCT05680818. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CALIBRATE: A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of the study is to understand the effectiveness, safety, and tolerability of encaleret when compared to standard of care (SoC) treatment in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1).

Study identification

NCT ID
NCT05680818
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
67 participants

Conditions and interventions

Interventions

Drug · Dietary Supplement

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 6, 2023 (Actual)
Primary completion
Aug 22, 2025 (Actual)
Completion
Aug 2029 (Estimated)
Last update posted
Jul 29, 2026

2023 – 2029

United States locations

U.S. sites
11
U.S. states
11
U.S. cities
11
Facility City State ZIP Site status
UCSF Benioff Children's Hospital, Oakland Oakland California 94609 —
Children's Hospital Colorado Aurora Colorado 80045 —
Indiana University Health University Hospital Indianapolis Indiana 46202 —
NIH Bethesda Maryland 20892 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Mayo Clinic - Rochester Rochester Minnesota 55905 —
Columbia University Irving Medical Center New York New York 10032 —
Physicians East Greenville North Carolina 27834 —
Ohio State University Medical Center Columbus Ohio 43203 —
The Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Houston Methodist Hospital Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05680818, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 29, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05680818 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →